GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phoenix Life Sciences International Ltd (OTCPK:PLSI) » Definitions » Cash Flow from Discontinued Operations

Phoenix Life Sciences International (Phoenix Life Sciences International) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Feb. 2019)


View and export this data going back to 2010. Start your Free Trial

What is Phoenix Life Sciences International Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Phoenix Life Sciences International's cash flow from discontinued operations for the three months ended in Feb. 2019 was $0.00 Mil. It means Phoenix Life Sciences International received $0.00 Mil from the sale of part of business quarterly. Phoenix Life Sciences International's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Feb. 2019 was $0.00 Mil.


Phoenix Life Sciences International Cash Flow from Discontinued Operations Historical Data

The historical data trend for Phoenix Life Sciences International's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phoenix Life Sciences International Cash Flow from Discontinued Operations Chart

Phoenix Life Sciences International Annual Data
Trend Feb11 Feb12 Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only - - - - -

Phoenix Life Sciences International Quarterly Data
May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Aug16 Nov16 Feb17 May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Phoenix Life Sciences International Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Feb. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Phoenix Life Sciences International Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Phoenix Life Sciences International's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Phoenix Life Sciences International (Phoenix Life Sciences International) Business Description

Traded in Other Exchanges
N/A
Address
4262 Blue Diamond Road, Suite 102-277, Las Vegas, NV, USA, 89139
Phoenix Life Sciences International Ltd is an adaptive healthcare solutions company. Its business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. The company strive to create partnerships and integrate these programs for human health into communities worldwide as part of its Global Health Initiative. Its products include Onco, Metabolic, Transdermal Patche, Medi-Strip Relaxation, and others.

Phoenix Life Sciences International (Phoenix Life Sciences International) Headlines